• go rss
상단검색

Date   :

~

Sort   :

IKMP Project

As national investment promotion agency of Korea, we select promising investment projects for Korean innovative venture companies and SMEs having foreign investment needs. Projects listed below is details and features of each project and their factsheets.

If you have any question about individual projects, please click the inquiry button in each project page. If you want to discover more about IKMP program, or want us to find specific company for you, please click 'General Inquiry' button below. You can leave your own inquiry through Non-Member log in.

 


Chemical/Material
  • 20200929085911
  • views :

Chemical/Material: Graphene-based Drug

  • Graphene-based nanomedicine: The company has developed a technology about pharmaceutical compositions for the prevention or treatment of neurodegenerative diseases, and which contains graphene nanostructures as an active ingredient. This pharmaceutical composition is the result of the first attempt ever to use graphene nanostructures for the prevention and treatment of neurodegenerative diseases. This technology can be applied to Parkinson's disease, which has the second highest incidence rate of all neurodegenerative diseases, and Niemann Pick disease, which is a rare and refractory children’s disease. • Neurodegenerative disease treatment market: The number of patients with degenerative brain diseases such as Alzheimer’s and Parkinson's disease is steadily increasing due to the global trend towards an aging population. According to the RENSIT and Harvard University survey reported in 2019, about 52.5 million patients suffer from various neurodegenerative diseases around the world, and 2.6 million patients die every year. The size of the global neurodegenerative disease treatment market stood at USD 35 billion in 2018, and is expected to grow at annual average growth rate of 7.4% to reach USD 62 million by 2026.
  •  
  • Investment Requirement

    • Amount : 1M
    • [true,false,true,false,""]
    • Region : USA, China, Japan
    Chemical/Material: Graphene-based Drug